Avricore Health (AVCRF) Common Equity (2009 - 2026)

Avricore Health (AVCRF) has reported Common Equity for 18 consecutive years, with $142343.1 the latest figure, recorded in Q1 2026.

• In Q1 2026, Common Equity fell 89.54% year-over-year to $142343.1; the TTM figure through Mar 2026 stood at $142343.1 (down 89.54% YoY), while the FY2025 annual figure was $278819.3, down 80.6% from the prior year.
• Common Equity slipped to $142343.1 in Q1 2026 per AVCRF's latest filing, from $279351.0 in the prior quarter.
• Across five years, Common Equity topped out at $1.8 million in Q3 2024 and bottomed at $142343.1 in Q1 2026.
• Historically, Common Equity has averaged $1.3 million across 5 years, with a median of $1.4 million in 2023.
• Annual changes were most pronounced in 2022 — Common Equity tumbled 93.63% — and 2024, when it soared 35.81%.
• Avricore Health's Common Equity stood at $1.4 million in 2022, then climbed by 1.98% to $1.5 million in 2023, then fell by 4.55% to $1.4 million in 2024, then sank by 80.17% to $279351.0 in 2025, then sank by 49.05% to $142343.1 in 2026.
• Business Quant data shows AVCRF's Common Equity at $142343.1 in Q1 2026, $279351.0 in Q4 2025, and $939833.3 in Q3 2025.